118 related articles for article (PubMed ID: 26059173)
1. Induction of apoptotic cell death by betulin in multidrug-resistant human renal carcinoma cells.
Yim NH; Jung YP; Kim A; Kim T; Ma JY
Oncol Rep; 2015 Aug; 34(2):1058-64. PubMed ID: 26059173
[TBL] [Abstract][Full Text] [Related]
2. Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells.
Li Y; He K; Huang Y; Zheng D; Gao C; Cui L; Jin YH
Mol Carcinog; 2010 Jul; 49(7):630-40. PubMed ID: 20564340
[TBL] [Abstract][Full Text] [Related]
3. mTOR activation is critical for betulin treatment in renal cell carcinoma cells.
Cheng W; Ji S; Zhang H; Han Z; Liu Q; Wang J; Ping H
Biochem Biophys Res Commun; 2017 Jan; 482(4):1030-1036. PubMed ID: 27908730
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells.
Wu XX; Kakehi Y; Mizutani Y; Nishiyama H; Kamoto T; Megumi Y; Ito N; Ogawa O
Int J Cancer; 2003 Apr; 104(4):409-17. PubMed ID: 12584736
[TBL] [Abstract][Full Text] [Related]
5. Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
Jin X; Wu XX; Jin C; Inui M; Sugimoto M; Kakehi Y
Anticancer Drugs; 2012 Apr; 23(4):445-54. PubMed ID: 22205156
[TBL] [Abstract][Full Text] [Related]
6. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
7. Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression.
Wu XX; Jin XH; Zeng Y; El Hamed AM; Kakehi Y
Cancer Sci; 2007 Dec; 98(12):1969-76. PubMed ID: 17922852
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
Elumalai P; Gunadharini DN; Senthilkumar K; Banudevi S; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
Toxicol Lett; 2012 Nov; 215(2):131-42. PubMed ID: 23089555
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.
Jin X; Wu XX; Abdel-Muneem Nouh MA; Kakehi Y
J Urol; 2007 May; 177(5):1894-9. PubMed ID: 17437844
[TBL] [Abstract][Full Text] [Related]
12. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry.
Pyo JS; Roh SH; Kim DK; Lee JG; Lee YY; Hong SS; Kwon SW; Park JH
Planta Med; 2009 Feb; 75(2):127-31. PubMed ID: 19085751
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
14. Betulin elicits anti-cancer effects in tumour primary cultures and cell lines in vitro.
Rzeski W; Stepulak A; Szymański M; Juszczak M; Grabarska A; Sifringer M; Kaczor J; Kandefer-Szerszeń M
Basic Clin Pharmacol Toxicol; 2009 Dec; 105(6):425-32. PubMed ID: 19821831
[TBL] [Abstract][Full Text] [Related]
15. α-Hispanolol sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis via death receptor up-regulation.
Mota A; Jiménez-Garcia L; Herránz S; de Las Heras B; Hortelano S
Toxicol Appl Pharmacol; 2015 Aug; 286(3):168-77. PubMed ID: 25930665
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL).
Pawlowski JE; Nesterov A; Scheinman RI; Johnson TR; Kraft AS
Anticancer Res; 2000; 20(6B):4243-55. PubMed ID: 11205254
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
Scheltema JM; Romijn JC; van Steenbrugge GJ; Schröder FH; Mickisch GH
Anticancer Res; 2001; 21(5):3161-6. PubMed ID: 11848468
[TBL] [Abstract][Full Text] [Related]
18. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells.
Perego P; Ciusani E; Gatti L; Carenini N; Corna E; Zunino F
Biochem Pharmacol; 2006 Mar; 71(6):791-8. PubMed ID: 16438941
[TBL] [Abstract][Full Text] [Related]
19. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells.
Choi YH; Baek JH; Yoo MA; Chung HY; Kim ND; Kim KW
Int J Oncol; 2000 Sep; 17(3):565-71. PubMed ID: 10938399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
